HomeNewsWorldUS plans for rapid vaccine rollout as COVID-19 surges to new heights

US plans for rapid vaccine rollout as COVID-19 surges to new heights

With outgoing President Donald Trump's coronavirus strategy relying heavily on a vaccine, the chief adviser of his administration's Operation Warp Speed program said on Tuesday that 20 million people could be inoculated by the end of 2020, and that by the middle of 2021 most Americans will have access to highly effective vaccines.

December 02, 2020 / 20:55 IST

U.S. officials on Tuesday unveiled plans to begin vaccinating millions of Americans against COVID-19 as early as mid-December, as coronavirus infections and hospitalizations in the United States soared once more to unprecedented heights.

With outgoing President Donald Trump's coronavirus strategy relying heavily on a vaccine, the chief adviser of his administration's Operation Warp Speed program said on Tuesday that 20 million people could be inoculated by the end of 2020, and that by the middle of 2021 most Americans will have access to highly effective vaccines.

"Within 24 hours, maybe at most 36 to 48 hours, from the approval, the vaccine can be in people's arms," Moncef Slaoui, a former GlaxoSmithKline executive, said at an event conducted by The Washington Post newspaper.

The highly contagious virus infected 4.36 million people in the United States in November alone, more than double the tally of new cases the previous month, as many Americans refused to wear masks and traveled for holiday gatherings against the recommendations of health experts.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

Some 60 million to 70 million doses of COVID-19 vaccine could be available per month beginning in January, after the expected regulatory approval of products from Pfizer Inc and Moderna Inc, Slaoui said.

A Food and Drug Administration panel of outside advisers will meet on Dec. 10 to discuss whether to recommend emergency use authorization of the Pfizer vaccine. They are expected to review Moderna's candidate a week later.

The distribution timeline described by Slaoui and U.S. Health and Human Services Secretary Alex Azar appeared to assume that the FDA's authorization of the first vaccine would come within days of the Dec. 10 meeting.

But the head of the FDA's Center for Biologics Evaluation and Research, Dr. Peter Marks, told patient advocacy groups last week that it might take "a few days to a few weeks" for his agency to render its decision.

FDA Commissioner Stephen Hahn has likewise said the process could take longer than the Trump administration has suggested.

Asked in a ABC News interview on Tuesday whether the vaccine could become available the week of Dec. 15, Hahn said: "It is possible," but noted, "it will depend on what sort of questions and data come out of the vaccine advisory committee."

The U.S. Transportation Department said on Tuesday it has made preparations to enable the "immediate mass shipment" of COVID-19 vaccines and completed all necessary regulatory measures.

A panel of advisers to the U.S. Centers for Disease Control and Prevention (CDC) on Tuesday voted 13-to-1 to recommend that healthcare workers and residents of long-term care facilities should be first in line to receive initial doses of COVID-19 vaccines when they become available.

The CDC will take the recommendation into account and provide guidance to the states to assist governors in their decisions about vaccine distribution priorities.

New York Governor Andrew Cuomo on Tuesday complained about the lack of federal funding for vaccine distribution. He also criticized a data-sharing agreement put forward by the government that he said could "dissuade undocumented immigrants from taking the vaccine."

Cuomo expressed concern that data on those receiving the vaccine could end up in the hands of U.S. Immigration and Customs Enforcement.

'TRAGICALLY FAMILIAR PATTERN'

Meanwhile, leading medical officials are pleading with Americans to abide by public health measures for slowing a pandemic that claimed 37,000 U.S. lives just last month.

A record nearly 96,000 COVID-19 patients were reported in U.S. hospitals on Tuesday, according to a Reuters tally.

Hospitalizations and deaths are expected to spike even higher in the midst of the holiday travel season, a trend that officials have warned will push an already strained healthcare system to the breaking point.

The monthly toll of U.S. COVID-19 deaths are projected to nearly double in December to a pandemic-high of more than 70,000 and surpass 76,000 in January before ebbing in February, according to a widely cited model from the University of Washington's Institute for Health Metrics and Evaluation.

The monthly record for U.S. COVID-19 deaths of 58,740 was set in April.

The pandemic and restrictions meant to stop it have ravaged the U.S. economy.

A bipartisan group of U.S. lawmakers on Tuesday unveiled a $908 billion COVID-19 relief bill aimed at breaking a monthslong deadlock between Democrats and Republicans over new emergency assistance for small businesses, unemployed people and industries.

U.S. nursing homes are experiencing the worst outbreak of weekly coronavirus cases since the spring, according to the American Health Care Association and National Center for Assisted Living (AHCA/NCAL).

New York City Health Commissioner Dr. Dave Chokshi urged at-risk residents to halt non-essential activities and stay in as much as possible as the city battles its second coronavirus wave.

"This escalation unfortunately follows a tragically familiar pattern - cases grow, hospitalizations follow," Chokshi said. "And, sadly, too many result in critical illness or even death."

Reuters
first published: Dec 2, 2020 07:32 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347